MétaCan
Menu
Back to cohort
Record W4312203309 · doi:10.1177/17411343221146094

Abbreviated new drug submission approval process: An overview

2022· article· en· W4312203309 on OpenAlexaboutno aff
Sonali S Amrutkar, Sanjay B. Patil, Atish S. Mundada

Bibliographic record

VenueJournal of Generic Medicines The Business Journal for the Generic Medicines Sector · 2022
Typearticle
Languageen
FieldEconomics, Econometrics and Finance
TopicPharmaceutical Economics and Policy
Canadian institutionsnot available
Fundersnot available
KeywordsBioequivalenceInnovatorGeneric drugBrand namesProduct (mathematics)DrugBusinessMedical prescriptionPrescription drugPharmacologyMarketingMedicineMathematicsFinancePharmacokinetics

Abstract

fetched live from OpenAlex

A generic drug is a copy of a brand name drug which can be introduced into the market once innovators patent expires. More than 73% of prescription drugs sold at retail in Canada are generics and thus Canada represents the world’s 9th biggest market for generic drugs in terms of value. Canada’s generic pharmaceutical sector produces domestically less than 10% of the active pharmaceutical ingredients used in its medicines. It also imports 88% of the finished dose products. Drug manufacturer has to demonstrate that its product is pharmacologically effective and bioequivalent to the innovator’s drug. The generic drug is bioequivalent or pharmaceutically equivalent to the Canadian Reference Product (CRP). The Abbreviated New Drug submission (ANDS) regulations were created to make the generic drug approval process simpler and more cost-effective by health drug Canada.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.066
metaresearch head score (Gemma)0.084
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: none
Teacher disagreement score0.066
Threshold uncertainty score0.347

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0660.084
Meta-epidemiology (narrow)0.0020.002
Meta-epidemiology (broad)0.0020.002
Bibliometrics0.0070.010
Science and technology studies0.0020.003
Scholarly communication0.0120.010
Open science0.0040.004
Research integrity0.0060.005
Insufficient payload (model declined to judge)0.0360.054

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.174
GPT teacher head0.344
Teacher spread0.170 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2022
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Generic Medicines The Business Journal for the Generic Medicines SectorSame topicPharmaceutical Economics and PolicyFrench-language works237,207